HMGA1染色质调节因子在MPN进展中诱导涉及GATA2和增殖的转录网络
该研究探讨HMGA1染色质调节因子在骨髓增殖性肿瘤(MPN)进展中的作用。在JAK2V617F小鼠及细胞模型中,HMGA1缺失可阻止向骨髓纤维化(MF)进展并延长生存,其机制涉及通过GATA2增强子调控增殖与细胞命运网络;HMGA1缺失还增强芦可替尼疗效。
要点
- HMGA1在MPN中上调,转化至MF或AML后水平最高。
- 缺失单个Hmga1等位基因即可阻止JAK2V617F小鼠向MF进展。
- HMGA1通过GATA2增强子(+9.5)反式激活GATA2并增加染色质可及性。
核心结论
- HMGA1是MPN转化的关键表观遗传开关,并是有望治疗或预防疾病进展的靶点。
研究设计与样本
- 研究在MPN模型中使用CRISPR/Cas9、短发夹RNA或遗传缺失破坏HMGA1基因表达,并结合RNA测序和染色质免疫沉淀测序分析。
主要发现
- 在JAK2V617F AML细胞系中敲低HMGA1可破坏增殖、克隆形成和白血病植入。
- JAK2V617F小鼠中缺失单个Hmga1等位基因可阻止向MF进展,减轻红细胞增多、血小板增多、巨核细胞增生及干祖细胞扩增,并防止脾脏和骨髓中的脾肿大和纤维化。
- 沉默GATA2可重现HMGA1缺失的大部分表型,而GATA2重新表达可部分挽救白血病发生。
- HMGA1通过发育增强子(+9.5)附近序列反式激活GATA2,增加染色质可及性并招募活性组蛋白标记。
- 在人类MF和MPN白血病转化中,包括增殖通路和GATA2在内的HMGA1转录网络被激活。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms (MPNs) transform to myelofibrosis (MF) and highly lethal acute myeloid leukemia (AML), although the actionable mechanisms driving progression remain elusive. Here, we elucidate the role of the high mobility group A1 (HMGA1) chromatin regulator as a novel driver of MPN progression. HMGA1 is upregulated in MPN, with highest levels after transformation to MF or AML. To define HMGA1 function, we disrupted gene expression via CRISPR/Cas9, short hairpin RNA, or genetic deletion in MPN models. HMGA1 depletion in JAK2V617F AML cell lines disrupts proliferation, clonogenicity, and leukemic engraftment. Surprisingly, loss of just a single Hmga1 allele prevents progression to MF in JAK2V617F mice, decreasing erythrocytosis, thrombocytosis, megakaryocyte hyperplasia, and expansion of stem and progenitors, while preventing splenomegaly and fibrosis within the spleen and BM. RNA-sequencing and chromatin immunoprecipitation sequencing revealed HMGA1 transcriptional networks and chromatin occupancy at genes that govern proliferation (E2F, G2M, mitotic spindle) and cell fate, including the GATA2 master regulatory gene. Silencing GATA2 recapitulates most phenotypes observed with HMGA1 depletion, whereas GATA2 re-expression partially rescues leukemogenesis. HMGA1 transactivates GATA2 through sequences near the developmental enhancer (+9.5), increasing chromatin accessibility and recruiting active histone marks. Further, HMGA1 transcriptional networks, including proliferation pathways and GATA2, are activated in human MF and MPN leukemic transformation. Importantly, HMGA1 depletion enhances responses to the JAK2 inhibitor, ruxolitinib, preventing MF and prolonging survival in murine models of JAK2V617F AML. These findings illuminate HMGA1 as a key epigenetic switch involved in MPN transformation and a promising therapeutic target to treat or prevent disease progression.
引用
- Li L, Kim JH, Lu W, et al. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression. Blood. 2022. PMID: 35286385. doi:10.1182/blood.2021013925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。